Valuation: Kamada Ltd.

Market Cap 144.56Cr 0 47Cr 41Cr 39Cr 35Cr 66Cr 4.55TCr 66Cr 463.3Cr 178.53Cr 2.31TCr 178.18Cr 174.25Cr 7.33TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 144.56Cr 0 47Cr 41Cr 39Cr 35Cr 66Cr 4.55TCr 66Cr 463.3Cr 178.53Cr 2.31TCr 178.18Cr 174.25Cr 7.33TCr EV / Sales 2026 *
2.39x
EV / Sales 2027 * 2.15x
Free-Float
54.4%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 58 01/07/2015
Director of Finance/CFO 56 31/12/2017
Chief Operating Officer 54 01/11/2016
Director TitleAgeSince
Director/Board Member 75 13/12/1990
Chairman 77 07/03/2013
Chairman 55 12/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-1.04% - - 47Cr
+1.57%-4.11%+41.74%-4.64% 7.93TCr
+1.89%+0.78%+523.95%+30.03% 5.86TCr
+1.57%-0.31%-14.78%-34.90% 5.86TCr
+0.35%-3.14%-11.03%+26.34% 4.87TCr
+2.38%+0.10%+1.49%+155.34% 4.63TCr
+0.10%-1.57%+50.05%-15.20% 3.21TCr
+0.59%-3.60%+47.04%+92.49% 2.48TCr
-1.86%-5.04%-0.47%+142.73% 2.15TCr
+2.24%-0.40%+66.12%+100.09% 1.6TCr
Average +0.65%-1.72%+78.24%+54.70% 4.29TCr
Weighted average by Cap. +0.93%-1.65%+94.53%+37.04%

Financials

2026 *2027 *
Net sales 61Cr 0 20Cr 17Cr 16Cr 15Cr 28Cr 1.91TCr 28Cr 194.17Cr 75Cr 966.74Cr 75Cr 73Cr 3.07TCr 67Cr 0 22Cr 19Cr 18Cr 16Cr 31Cr 2.12TCr 31Cr 215.76Cr 83Cr 1.07TCr 83Cr 81Cr 3.42TCr
Net income 8.48Cr 0 2.78Cr 2.41Cr 2.28Cr 2.06Cr 3.87Cr 266.71Cr 3.9Cr 27Cr 10Cr 135.3Cr 10Cr 10Cr 430.15Cr 10Cr 0 3.42Cr 2.96Cr 2.79Cr 2.53Cr 4.75Cr 327.48Cr 4.79Cr 33Cr 13Cr 166.13Cr 13Cr 13Cr 528.16Cr
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
-
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!